The weed wire Canopy launches CBD website in US despite lack of FDA regulations Company now sells CBD sport supplements online despite the US FDA not approving those products Jared GnamJuly 27, 2020
CBD FDA issues cannabis research guidelines as CBD industry still hangs in limbo Vermont cannabis lawyer Timothy Fair calls FDA's two-year delay on CBD regulations 'beyond absurd' Jared GnamJuly 24, 2020
The weed wire Aleafia Health clinics to offer ketamine-based antidepressant Spravato can be prescribed for treatment-resistant depressive disorder Michelle GamageJuly 24, 2020
Industry update Canopy to launch Martha Stewart CBD brand this fall Canadian weed giant has been working with the US FDA to get CBD food and pet products regulated Jared GnamJune 26, 2020
Industry update Charlotte’s Web backs study on health outcomes of CBD Third-party study aims to provide U.S. FDA with new science to expedite creation of a regulatory framework Jared GnamJune 10, 2020
The weed wire Aurora continues winning streak on US CBD deal US$40M acquisition of Reliva gives Aurora the No. 2 US CBD brand by market share Jared GnamMay 21, 2020
COVID-19 Tetra Bio-Pharma gets 5th orphan drug status for CBD topical The company is expanding its strategy of obtaining rare drug designations for cannabis-based drugs during the pandemic Jared GnamApril 23, 2020
Enforcement Florida’s new medical cannabis limits could drive patients underground: lawyer State has voted to cap THC potency at 10% for patients under 21, edibles at 200 mg Michelle GamageMarch 9, 2020